StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.62−0.06 (-2.24%)

Close on Nov 13, 2026Market cap $91.08MP/E –Yield –

Anixa Biosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Anixa Biosciences's EV/EBITDA was 23.3× on May 29, 2015.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2015May 29, 201523.3×–

More Anixa Biosciences figures

See a number that looks wrong?